New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments

Currently, there are no effective drugs for the treatment of amyotrophic lateral sclerosis (ALS). Only two drugs—edaravone and riluzole—have been approved, but they have very limited efficacy. The aim of this work was to modify the structural core of the Edaravone—phenylpyrazolone moiety and combine...

Description complète

Détails bibliographiques

Auteurs principaux:	Maria A. Lapshina, Elena F. Shevtsova, Vladimir V. Grigoriev, Aleksey Yu. Aksinenko, Aleksey A. Ustyugov, Daniil A. Steinberg, Grigoriy V. Maleev, Elena S. Dubrovskaya, Tatiana V. Goreva, Tatiana A. Epishina, Vladimir L. Zamoyski, Galina F. Makhaeva, Vladimir P. Fisenko, Ivan M. Veselov, Daria V. Vinogradova, Sergey O. Bachurin
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2023-11-01
Collection:	Molecules
Sujets:	amyotrophic lateral sclerosis (ALS) edaravone aminoadamantanes lipid peroxidation mitochondria FUS protein
Accès en ligne:	https://www.mdpi.com/1420-3049/28/22/7567
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!